Schubert & CO Corcept Therapeutics Inc Transaction History

Schubert & CO

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 02, 2023	BUY	$19.2 - $24.47 $19 - $24	1 Added 20.0%	6 $0
Q4 2022 Jan 31, 2023	SELL	$19.95 - $29.96 $119 - $179	-6 Reduced 54.55%	5 $0
Q3 2022 Oct 21, 2022	BUY	$24.7 - $29.12 $49 - $58	2 Added 22.22%	11 $0
Q2 2022 Aug 01, 2022	BUY	$17.33 - $25.3 $51 - $75	3 Added 50.0%	9 $0
Q1 2022 May 16, 2022	BUY	$16.53 - $25.21 $49 - $75	3 Added 100.0%	6 $0
Q4 2021 Jan 28, 2022	BUY	$17.1 - $23.34 $51 - $70	3 New	3 $0

403

84.3M

1.04M

1.33M

Ticker CORT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,105,000
Market Cap $5.87B
Description
Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...

Get notified when there are updates to the investment portfolio of Schubert & CO, based on Form 13F filings with the SEC.

Stay updated on Schubert & CO with notifications on news.